Pediatric Blood & Cancer

Pediatric Blood & Cancer (commonly abbreviated as Pediatr. Blood Cancer) is a peer-reviewed journal of paediatric oncology and haematology published by Wiley, issued monthly. It descends from Medical and Pediatric Oncology, founded in 1975, adopted its present title in 2004 and became online-only in 2014.《儿科血液与癌症》（Pediatric Blood & Cancer，常用缩写为 Pediatr. Blood Cancer）是一份由威立出版出版的儿科肿瘤与血液病同行评审学术期刊，月刊。该刊源自 1975 年创刊的《医学与儿科肿瘤学》，2004 年改用现名，2014 年起转为纯在线出版。

Scope

The journal's editorial stance takes children, adolescents and young adults as its sole subject, requiring that the blood disorder or malignant disease studied occur in those populations rather than being extrapolated to paediatrics from adult conclusions. It stresses both basic and clinical work, accepting the whole chain from aetiology and biology to treatment and supportive care. Its principal subject areas include:本刊的取稿立场是「以儿童、青少年与青年人为唯一对象」，即要求论文所研究的血液病或恶性疾病须发生在儿童、青少年与青年人群中，而非仅在成人结论上作儿科外推。刊物同时强调基础与临床并重，从病因、生物学到诊疗与支持治疗的全链条均可收。收文覆盖的主要方向包括：

• Childhood leukaemia: risk-adapted therapy, relapse and long-term prognosis in acute lymphoblastic and other childhood leukaemias.儿童白血病： 急性淋巴细胞白血病与其他儿童白血病的分层治疗、复发与长期预后。
• Solid tumours: the biology and treatment of childhood solid tumours including neuroblastoma, Wilms tumour and retinoblastoma.实体瘤： 神经母细胞瘤、肾母细胞瘤、视网膜母细胞瘤等儿童实体瘤的生物学与治疗。
• Haematopoietic stem cell transplantation: indications, donor selection, management of complications, and quality of life after transplantation.造血干细胞移植： 移植适应证、供者选择、并发症管理与移植后生存质量。
• Genetic and molecular mechanisms: molecular and clinical genetics of childhood blood disorders and tumours, together with predisposition syndromes.遗传与分子机制： 儿童血液病与肿瘤的分子与临床遗传学，以及易感综合征。
• Supportive care and survivorship: infection prevention, nutritional support, late effects of treatment, and long-term follow-up of survivors.支持治疗与生存者照护： 感染防治、营养支持、治疗相关远期效应与生存者的长期随访。

The journal is a hybrid title. The subscription route charges authors nothing, while open access carries an article processing charge. The publisher publishes neither an acceptance rate nor a review duration for this title, and the library's previous figures of about 25 per cent and about a month and a half had no official basis and have been deleted. The journal is indexed in the Science Citation Index Expanded and carries a 2025 impact factor of 2.4.该刊属混合出版模式：订阅路线不向作者收费，选择开放获取需支付文章处理费。出版方不公布该刊录用比例与审稿时长，库内原记录用率约 25% 与审稿约一个半月均无官方依据，已删除。该刊被科学引文索引扩展版收录，2025 年影响因子 2.4。

History

• Founding and renaming (1975–2004): the journal was founded in 1975 under the name Medical and Pediatric Oncology, adopting its present title from January 2004. The library's history start of 1975 agrees with its record of the former title.创刊与更名（1975–2004）： 本刊创刊于 1975 年，创刊刊名为《医学与儿科肿瘤学》，2004 年 1 月起改用现名；库内沿革起点 1975 年与前身刊名记录一致。^[1]
• Moving online-only (2014): the journal became online-only in January 2014 and no longer issues a print edition, a step in step with the digital turn in paediatric oncology.转纯在线（2014年）： 该刊自 2014 年 1 月起转为纯在线出版，不再发行印刷版；这一节点与其在儿科肿瘤学领域的数字化转型同步。^[2]
• Current editor: Peter E. Newburger serves as editor, based at the University of Massachusetts Medical School, his editorship consistent across the publisher's records and third-party journal directories. The library's previously missing editor field has been filled in from the official page.现任主编： 彼得·纽伯格（Peter E. Newburger）任主编，供职于马萨诸塞大学医学院；其主编身份在出版方与第三方期刊名录中一致。库内原缺编辑字段，已按官方页补入。^[3]
• Publisher relationship: the journal is published by Wiley, with the editorial office sharing editorial and submission platforms with that publisher's other medical titles. The library's publisher record agrees with the current arrangement.出版方关系： 本刊由威立出版，编辑部与该社其他医学刊物共用编辑与投稿平台；库内所记出版方与现行安排一致。^[2]
• Metric trend: the 2025 impact factor of 2.4, together with a CiteScore of 3.9, places the journal in the middle to upper range across the paediatrics, haematology and oncology categories.指标走势： 影响因子自 2025 年的 2.4 与引用分数 3.9 共同刻画该刊位置；在儿科学、血液病学与肿瘤学三个类目中均居中等偏上位置。^[3]
• Acceptance and speed: the publisher publishes neither an acceptance rate nor a review duration for this title. The library's previous figures of about 25 per cent and about a month and a half had no official basis and have been deleted.录用与时效： 出版方不公布该刊录用率与审稿时长；库内原记录用率约 25% 与审稿约一个半月均无官方依据，已删除。^[3]

Editors

The journal operates under a single editor appointed by Wiley, with manuscripts submitted through the publisher's own submission system. The publisher publishes no editorial process detail beyond the journal's positioning, and the composition of the editorial office is taken from the masthead.本刊实行主编负责制，主编由威立出版任命并主持编辑部；稿件经出版方自有的投稿系统投递。官方不公布除期刊定位之外的编辑流程细节，编辑部构成以刊头署名为准。

• Peter E. Newburger (current editor): professor at the University of Massachusetts Medical School, working on childhood bone marrow failure syndromes and inherited blood disorders, his editorship consistent across the publisher's records and third-party journal directories.彼得·纽伯格（现任主编）： 马萨诸塞大学医学院教授，研究方向为儿童骨髓衰竭综合征与遗传性血液病；其主编身份在出版方与第三方期刊名录中一致。^[3]
• Selection threshold: the journal describes itself as publishing the highest-quality manuscripts on the basic and clinical investigation of blood disorders and malignant diseases of childhood, covering diagnosis, treatment, epidemiology, aetiology, biology and molecular clinical genetics, a threshold that requires findings to hold in paediatric populations.取稿门槛： 刊物自述发表关于儿童血液病与恶性疾病的基础与临床研究的最高质量稿件，覆盖诊断、治疗、流行病学、病因、生物学与分子临床遗传学，这一门槛要求论文须在儿科人群中成立。^[3]
• The earlier title: from 1975 to 2004 the journal appeared under the name Medical and Pediatric Oncology, a period that formed its early volumes and editorial structure, for which the publisher has not published a list of first and successive editors.前身刊时期： 1975 至 2004 年本刊以《医学与儿科肿瘤学》为名出版，该时期为其早期卷期与编辑架构的形成阶段，具体首任与历任主编名单出版方未公布。^[1]
• Acceptance and speed: the publisher publishes neither an acceptance rate nor a review duration, and supplying specific figures would amount to fabrication. Practical accounts of the journal's review duration come mainly from submission experience posts and carry no authority.录用与时效： 出版方不公布该刊录用率与审稿时长，补写具体数字只会造成编造；该刊在实务上的审稿时长以投稿经验帖为主，不具备权威性。^[3]
• Standing in the field: the journal is one of the principal titles in paediatric haematology and oncology, its clinical research cited directly in relevant guidelines, and together with the other specialty titles in the field it forms the publication base of paediatric oncology.学科地位： 该刊是儿科血液病与肿瘤学方向的主要刊物之一，其临床研究常被相关指南直接引用，与该领域其他专科刊物共同构成儿科肿瘤学的发表底座。^[3]